BioProtect
Tsur Moshe
About BioProtect
BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CE marked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $71.9M
- Last round: Series Unknown (May 2025)
- Website: bioprotect.com
- Phone: +972-9-773-1929
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/bioprotect-67801 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.